Highlights

[PHARMA] QoQ Quarter Result on 2018-06-30 [#2]

Stock [PHARMA]: PHARMANIAGA BHD
Announcement Date 17-Aug-2018
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2018
Quarter 30-Jun-2018  [#2]
Profit Trend QoQ -     -69.33%    YoY -     -43.34%
Quarter Report


View:


Show?  QoQ % Horiz. %

Quarter Result
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Revenue 786,108 596,644 587,660 582,729 617,923 613,196 574,503 23.28%
  QoQ % 31.75% 1.53% 0.85% -5.70% 0.77% 6.74% -
  Horiz. % 136.83% 103.85% 102.29% 101.43% 107.56% 106.74% 100.00%
PBT 30,243 11,940 17,603 11,970 28,707 19,866 15,271 57.77%
  QoQ % 153.29% -32.17% 47.06% -58.30% 44.50% 30.09% -
  Horiz. % 198.04% 78.19% 115.27% 78.38% 187.98% 130.09% 100.00%
Tax -10,595 -7,370 -2,298 -6,204 -11,118 2,222 -11,381 -4.66%
  QoQ % -43.76% -220.71% 62.96% 44.20% -600.36% 119.52% -
  Horiz. % 93.09% 64.76% 20.19% 54.51% 97.69% -19.52% 100.00%
NP 19,648 4,570 15,305 5,766 17,589 22,088 3,890 194.67%
  QoQ % 329.93% -70.14% 165.44% -67.22% -20.37% 467.81% -
  Horiz. % 505.09% 117.48% 393.44% 148.23% 452.16% 567.81% 100.00%
NP to SH 19,617 4,437 15,051 5,394 17,586 21,700 3,580 211.14%
  QoQ % 342.12% -70.52% 179.03% -69.33% -18.96% 506.15% -
  Horiz. % 547.96% 123.94% 420.42% 150.67% 491.23% 606.15% 100.00%
Tax Rate 35.03 % 61.73 % 13.05 % 51.83 % 38.73 % -11.18 % 74.53 % -39.58%
  QoQ % -43.25% 373.03% -74.82% 33.82% 446.42% -115.00% -
  Horiz. % 47.00% 82.83% 17.51% 69.54% 51.97% -15.00% 100.00%
Total Cost 766,460 592,074 572,355 576,963 600,334 591,108 570,613 21.76%
  QoQ % 29.45% 3.45% -0.80% -3.89% 1.56% 3.59% -
  Horiz. % 134.32% 103.76% 100.31% 101.11% 105.21% 103.59% 100.00%
Net Worth 528,825 509,862 522,618 519,642 524,838 526,888 531,892 -0.39%
  QoQ % 3.72% -2.44% 0.57% -0.99% -0.39% -0.94% -
  Horiz. % 99.42% 95.86% 98.26% 97.70% 98.67% 99.06% 100.00%
Dividend
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Div 15,630 5,202 13,000 10,392 12,991 15,573 12,973 13.24%
  QoQ % 200.43% -59.98% 25.09% -20.00% -16.58% 20.04% -
  Horiz. % 120.48% 40.10% 100.21% 80.11% 100.14% 120.04% 100.00%
Div Payout % 79.68 % 117.26 % 86.38 % 192.67 % 73.87 % 71.77 % 362.37 % -63.60%
  QoQ % -32.05% 35.75% -55.17% 160.82% 2.93% -80.19% -
  Horiz. % 21.99% 32.36% 23.84% 53.17% 20.39% 19.81% 100.00%
Equity
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Net Worth 528,825 509,862 522,618 519,642 524,838 526,888 531,892 -0.39%
  QoQ % 3.72% -2.44% 0.57% -0.99% -0.39% -0.94% -
  Horiz. % 99.42% 95.86% 98.26% 97.70% 98.67% 99.06% 100.00%
NOSH 260,505 260,134 260,009 259,821 259,821 259,551 259,460 0.27%
  QoQ % 0.14% 0.05% 0.07% 0.00% 0.10% 0.04% -
  Horiz. % 100.40% 100.26% 100.21% 100.14% 100.14% 100.04% 100.00%
Ratio Analysis
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
NP Margin 2.50 % 0.77 % 2.60 % 0.99 % 2.85 % 3.60 % 0.68 % 138.40%
  QoQ % 224.68% -70.38% 162.63% -65.26% -20.83% 429.41% -
  Horiz. % 367.65% 113.24% 382.35% 145.59% 419.12% 529.41% 100.00%
ROE 3.71 % 0.87 % 2.88 % 1.04 % 3.35 % 4.12 % 0.67 % 213.32%
  QoQ % 326.44% -69.79% 176.92% -68.96% -18.69% 514.93% -
  Horiz. % 553.73% 129.85% 429.85% 155.22% 500.00% 614.93% 100.00%
Per Share
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
RPS 301.76 229.36 226.02 224.28 237.83 236.25 221.42 22.95%
  QoQ % 31.57% 1.48% 0.78% -5.70% 0.67% 6.70% -
  Horiz. % 136.28% 103.59% 102.08% 101.29% 107.41% 106.70% 100.00%
EPS 7.53 1.71 5.79 2.08 6.77 8.36 1.38 210.26%
  QoQ % 340.35% -70.47% 178.37% -69.28% -19.02% 505.80% -
  Horiz. % 545.65% 123.91% 419.57% 150.72% 490.58% 605.80% 100.00%
DPS 6.00 2.00 5.00 4.00 5.00 6.00 5.00 12.94%
  QoQ % 200.00% -60.00% 25.00% -20.00% -16.67% 20.00% -
  Horiz. % 120.00% 40.00% 100.00% 80.00% 100.00% 120.00% 100.00%
NAPS 2.0300 1.9600 2.0100 2.0000 2.0200 2.0300 2.0500 -0.65%
  QoQ % 3.57% -2.49% 0.50% -0.99% -0.49% -0.98% -
  Horiz. % 99.02% 95.61% 98.05% 97.56% 98.54% 99.02% 100.00%
Adjusted Per Share Value based on latest NOSH - 261,230
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
RPS 300.93 228.40 224.96 223.07 236.54 234.73 219.92 23.28%
  QoQ % 31.76% 1.53% 0.85% -5.69% 0.77% 6.73% -
  Horiz. % 136.84% 103.86% 102.29% 101.43% 107.56% 106.73% 100.00%
EPS 7.51 1.70 5.76 2.06 6.73 8.31 1.37 211.22%
  QoQ % 341.76% -70.49% 179.61% -69.39% -19.01% 506.57% -
  Horiz. % 548.18% 124.09% 420.44% 150.36% 491.24% 606.57% 100.00%
DPS 5.98 1.99 4.98 3.98 4.97 5.96 4.97 13.14%
  QoQ % 200.50% -60.04% 25.13% -19.92% -16.61% 19.92% -
  Horiz. % 120.32% 40.04% 100.20% 80.08% 100.00% 119.92% 100.00%
NAPS 2.0244 1.9518 2.0006 1.9892 2.0091 2.0169 2.0361 -0.38%
  QoQ % 3.72% -2.44% 0.57% -0.99% -0.39% -0.94% -
  Horiz. % 99.43% 95.86% 98.26% 97.70% 98.67% 99.06% 100.00%
Price Multiplier on Financial Quarter End Date
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Date 29/03/19 31/12/18 28/09/18 29/06/18 30/03/18 29/12/17 29/09/17 -
Price 2.2700 2.7800 2.8900 2.8800 4.2800 4.6000 4.1400 -
P/RPS 0.75 1.21 1.28 1.28 1.80 1.95 1.87 -45.65%
  QoQ % -38.02% -5.47% 0.00% -28.89% -7.69% 4.28% -
  Horiz. % 40.11% 64.71% 68.45% 68.45% 96.26% 104.28% 100.00%
P/EPS 30.14 162.99 49.93 138.73 63.23 55.02 300.05 -78.42%
  QoQ % -81.51% 226.44% -64.01% 119.41% 14.92% -81.66% -
  Horiz. % 10.04% 54.32% 16.64% 46.24% 21.07% 18.34% 100.00%
EY 3.32 0.61 2.00 0.72 1.58 1.82 0.33 366.69%
  QoQ % 444.26% -69.50% 177.78% -54.43% -13.19% 451.52% -
  Horiz. % 1,006.06% 184.85% 606.06% 218.18% 478.79% 551.52% 100.00%
DY 2.64 0.72 1.73 1.39 1.17 1.30 1.21 68.30%
  QoQ % 266.67% -58.38% 24.46% 18.80% -10.00% 7.44% -
  Horiz. % 218.18% 59.50% 142.98% 114.88% 96.69% 107.44% 100.00%
P/NAPS 1.12 1.42 1.44 1.44 2.12 2.27 2.02 -32.53%
  QoQ % -21.13% -1.39% 0.00% -32.08% -6.61% 12.38% -
  Horiz. % 55.45% 70.30% 71.29% 71.29% 104.95% 112.38% 100.00%
Price Multiplier on Announcement Date
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Date 16/05/19 21/02/19 19/11/18 17/08/18 16/05/18 27/02/18 15/11/17 -
Price 2.3600 2.7600 3.0900 3.1100 4.0700 4.0400 3.8200 -
P/RPS 0.78 1.20 1.37 1.39 1.71 1.71 1.73 -41.23%
  QoQ % -35.00% -12.41% -1.44% -18.71% 0.00% -1.16% -
  Horiz. % 45.09% 69.36% 79.19% 80.35% 98.84% 98.84% 100.00%
P/EPS 31.34 161.81 53.38 149.80 60.13 48.32 276.85 -76.63%
  QoQ % -80.63% 203.13% -64.37% 149.13% 24.44% -82.55% -
  Horiz. % 11.32% 58.45% 19.28% 54.11% 21.72% 17.45% 100.00%
EY 3.19 0.62 1.87 0.67 1.66 2.07 0.36 328.78%
  QoQ % 414.52% -66.84% 179.10% -59.64% -19.81% 475.00% -
  Horiz. % 886.11% 172.22% 519.44% 186.11% 461.11% 575.00% 100.00%
DY 2.54 0.72 1.62 1.29 1.23 1.49 1.31 55.55%
  QoQ % 252.78% -55.56% 25.58% 4.88% -17.45% 13.74% -
  Horiz. % 193.89% 54.96% 123.66% 98.47% 93.89% 113.74% 100.00%
P/NAPS 1.16 1.41 1.54 1.56 2.01 1.99 1.86 -27.03%
  QoQ % -17.73% -8.44% -1.28% -22.39% 1.01% 6.99% -
  Horiz. % 62.37% 75.81% 82.80% 83.87% 108.06% 106.99% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View Trading Signals and run Live Backtest
MQ Affiliate
Earn rewards with MQ Affiliate Program
 
 

237  654  558  1002 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AT 0.095+0.005 
 LCTITAN 2.14-0.26 
 SUPERMX-C1I 0.145-0.005 
 LUSTER 0.165-0.005 
 MAHSING 0.965-0.035 
 HWGB 0.77+0.055 
 DATAPRP 0.19-0.03 
 DGSB 0.225+0.01 
 MTOUCHE 0.05-0.005 
 KSTAR 0.43+0.06 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Supermax: my revised target price - Koon Yew Yin Koon Yew Yin's Blog
2. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
3. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
4. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
5. [Humbled Investor] Supermx - Superb results - Estimation on Next QR Results HumbledInvestor
6. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
7. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
8. Traders Brief 27 Oct 2020 - Volatility Ahead Amid Internal and External Headwinds HLBank Research Highlights
PARTNERS & BROKERS